Skip to main content

BioNTech SE (BNTX)

NASDAQ: BNTX · IEX Real-Time Price · USD
-1.41 (-0.48%)
After-hours:Oct 25, 2021 7:59 PM EDT
16.58 (5.96%)
At close: Oct 25, 4:00 PM

Total Valuation

BioNTech SE has a market cap or net worth of $71.52 billion. The enterprise value is $70.30 billion.

Market Cap71.52B
Enterprise Value70.30B

Important Dates

The next estimated earnings date is Nov 9, 2021, which is a Tuesday.

Estimated Earnings DateNov 9, 2021
Ex-Dividend Daten/a

Share Statistics

BioNTech SE has 242.52 million shares outstanding.

Shares Outstanding242.52M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)1.16%
Owned by Institutions (%)16.59%

Valuation Ratios

The trailing PE ratio is 16.40 and the forward PE ratio is 6.13. BioNTech SE's PEG ratio is 0.05.

PE Ratio16.40
Forward PE6.13
PS Ratio121.60
PB Ratio42.75
P/FCF Ration/a
PEG Ratio0.05
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earnings3,793.08
EV / Sales119.52
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.25.

Current Ratio2.75
Quick Ratio2.50
Debt / Equity0.25
Debt / EBITDA-8.21
Debt / FCF-3.54

Financial Efficiency

Return on equity (ROE) is 1.60%, which is considered low. The company has a ROIC of -19.70%.

Return on Equity (ROE)1.60%
Return on Assets (ROA)1.00%
Return on Capital (ROIC)-19.70%
Revenue Per Employee$235,280
Profits Per Employee$7,414
Employee Count2,500
Asset Turnover0.31
Inventory Turnover1.70


Income Tax-196.34M
Effective Tax Rate110.42%

Stock Price Statistics

The stock price has increased by +213.83% in the last 52 weeks. The beta is -1.16, so BioNTech SE's price volatility has been lower than the market average.

Beta (1Y)-1.16
52-Week Price Change+213.83%
50-Day Moving Average295.51
200-Day Moving Average258.86
Average Volume (30 Days)2,814,609

Short Selling Information

Short Interest2.29M
Short % of Shares Out0.94%
Short % of Float2.94%
Short Ratio (days to cover)0.71

Income Statement

In the last 12 months, BioNTech SE had revenue of 588.20 million and earned 18.53 million in profits. Earnings per share was $17.99.

Gross Profit515.84M
Operating Income-100.51M
Pretax Income-177.81M
Net Income18.53M
Earnings Per Share (EPS)$17.99
Full Income Statement

Balance Sheet

The company has $1.64 billion in cash and $421.63 million in debt, giving a net cash position of $1.22 billion or $5.04 per share.

Cash & Cash Equivalents1.64B
Total Debt421.63M
Net Cash1.22B
Net Cash Per Share$5.04
Book Value1.67B
Book Value Per Share6.90
Working Capital1.29B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.43 million and capital expenditures -$102.69 million, giving a free cash flow of -$119.12 million.

Operating Cash Flow-16.43M
Capital Expenditures-102.69M
Free Cash Flow-119.12M
FCF Per Share-$0.49
Full Cash Flow Statement


Gross margin is 87.70%, with operating and profit margins of -17.09% and 3.15%.

Gross Margin87.70%
Operating Margin-17.09%
Pretax Margin-30.23%
Profit Margin3.15%
EBITDA Margin-8.73%
EBIT Margin-16.76%
FCF Margin-20.25%

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield0.03%
FCF Yield-0.17%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a